Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical application of serum biomarkers for detecting and monitoring of chronic plaque psoriasis. | Front Mol Biosci | 2023 | 37546687 | PubTator, text mining | PubMed |
| Atopic dermatitis and gestational age - is there an association between them? A review of the literature and an analysis of pathology. | Postepy Dermatol Alergol | 2023 | 37545834 | PubTator, text mining | PubMed |
| Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study. | Front Immunol | 2023 | 37545503 | PubTator, text mining | PubMed |
| Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment. | Am J Physiol Cell Physiol | 2023 | 37545408 | PubTator, text mining | PubMed |
| Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions. | J Neuromuscul Dis | 2023 | 37545256 | PubTator, text mining | PubMed |
| Role of interleukin-36γ induced by ultraviolet radiation in chronic actinic dermatitis. | Photodermatol Photoimmunol Photomed | 2023 | 37545106 | PubTator, text mining | PubMed |
| A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. | Nat Commun | 2023 | 37542039 | PubTator, text mining | PubMed |
| ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression. | Front Immunol | 2023 | 37539056 | PubTator, text mining | PubMed |
| Cigarette smoking exposure disrupts the regenerative potential of dental pulp stem cells. | Tob Induc Dis | 2023 | 37533959 | PubTator, text mining | PubMed |
| Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy. | Clin Transl Med | 2023 | 37525587 | PubTator, text mining | PubMed |
| Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway. | Indian Dermatol Online J | 2023 | 37521227 | PubTator, text mining | PubMed |
| Systemic inflammatory proteins in offspring following maternal probiotic supplementation for atopic dermatitis prevention. | Clin Mol Allergy | 2023 | 37516841 | PubTator, text mining | PubMed |
| How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19. | Viruses | 2023 | 37515272 | PubTator, text mining | PubMed |
| Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma. | Life (Basel) | 2023 | 37511958 | PubTator, text mining | PubMed |
| Chlamydial and Gonococcal Genital Infections: A Narrative Review. | J Pers Med | 2023 | 37511783 | PubTator, text mining | PubMed |
| From Teeth to Therapy: A Review of Therapeutic Potential within the Secretome of Stem Cells from Human Exfoliated Deciduous Teeth. | Int J Mol Sci | 2023 | 37511524 | PubTator, text mining | PubMed |
| Pulmonary Sarcoidosis: Experimental Models and Perspectives of Molecular Diagnostics Using Quantum Dots. | Int J Mol Sci | 2023 | 37511027 | PubTator, text mining | PubMed |
| Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal Ligament. | Biomedicines | 2023 | 37509659 | PubTator, text mining | PubMed |
| Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency. | Biomedicines | 2023 | 37509640 | PubTator, text mining | PubMed |
| TIME Is Ticking for Cervical Cancer. | Biology (Basel) | 2023 | 37508372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=28